Company / Goodwill
X4 Pharmaceuticals, Inc Goodwill History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$17.4M
FY2025
5-year range
$17.4M / $27.1M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $27M to $17M over the past 3 years.
Based on SEC 10-K filings.
$17M in FY2025 with a 5-year CAGR of -8.5%.
Declined from $27M to $17M over the past 3 years.
Goodwill over time
Growth rates
- 3-Year CAGR
- -13.8%
- 5-Year CAGR
- -8.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -8.5%, indicating a declining trend.
- In FY2025, goodwill increased 0.0% year-over-year.
- Peak goodwill was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.4M | +0.0% |
| FY2024 | $17.4M | -36.0% |
| FY2022 | $27.1M | +0.0% |
| FY2021 | $27.1M | +0.0% |
| FY2020 | $27.1M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026